The Fourth Circuit reverses a decision allowing a company to litigate under a pseudonym, requiring litigants seeking to seal any portion of the record to demonstrate a compelling interest.
An in-house attorney with Bristol-Myers Squibb Co. shares her proudest accomplishment and advice to young lawyers as well as lawyers considering the move to in-house legal work.
After years of delay, the NHTSA finalizes a rule requiring certain new vehicles manufactured after May 2018 to have rear visibility technology.
By Heidi Oertle and Shawna Boothe
When a party's physical or mental condition is at issue, an independent medical examination may be ordered as a matter of right or upon a showing of good cause. Who may conduct the exam and whether the attorney may be present varies among the states.
By John Camp and L. Vanessa Lopez
General document preservation holds may impose a duty to preserve documents for unforeseen litigation, where that duty may not have otherwise existed.
By Michael A. Preciado
Autonomous vehicles have driven off the pages of Hollywood scripts onto real streets. The law must likewise evolve to protect manufacturers and the public from drivers who carelessly fail to update their vehicle's software.
Clients defending class actions in the United States often end up defending a similar action in Canada, and vice versa. Lawrie discusses Canadian certification experiences that may be different compared to their U.S. counterparts.(09:42 min)
The ever-changing role of social media has created many new potential legal issues. Listen to longtime litigator Lori Leskin's analysis of recent FDA guidance on the use of social media in the pharmaceutical industry. (12:14 min)
Kristie Wetterer outlines key points to keep in mind upon receipt of a complaint, when crafting an answer, and initial case assessment and discovery. (07:49 min)
Learn about the significance of the Barltett decision and its impact on the court's preemption holdings. (00:57:33)
Young lawyers today face various challenges as they work to further their careers, from establishing and expanding a network to finding a good advocate who will help advance their career. Join us for a discussion on how can young lawyers turn these challenges into opportunities. (01:13:25)
The difference between biologics and small molecule therapeutics—the types of drugs most products lawyers have litigated to date—as well as recent developments stemming from the 2010 Affordable Care Act will be the focus of this roundtable. (56:26)
Join us in Boston for the 2014 ABA Annual Conference!
We hope that you can join us for the 2014 Regional Pharmaceutical & Medical Device CLE Seminar on Thursday, October 9, 2014, at Norton Rose Fulbright in Austin, Texas.
The YLS monthly call will take place on the first Tuesday of every month at 3 p.m. Eastern time.